Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Glioma 6 Glioblastoma 3 Insulinoma 2 Hypoglycemia 2 Hyperinsulinism 2 Congenital Hyperinsulinism 2 Brain Neoplasms 2 Sarcoma 1 Pheochromocytoma 1 Parkinsonian Disorders 1 Parkinson Disease 1 Oligodendroglioma 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms 1 Lewy Body Disease 1 Infant, Newborn, Diseases 1 Glucose Metabolism Disorders 1 Gliosarcoma 1 Glioma, Subependymal 1 Ependymoma 1 Endocrine System Diseases 1 Carcinoma, Medullary 1 Carcinoid Tumor 1 Beckwith-Wiedemann Syndrome 1 Astrocytoma 1

Interventions

zimberelimab 1 pembrolizumab 1 olaparib 1 lutetium Lu 177 dotatate 1 lanreotide 1 fluorodopa F 18 1 cabozantinib 1 Sunitinib 1 Random Allocation 1 Octreotide 1 Nivolumab 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoid Tumor × fluorodopa F 18 × 1 year × Clear all

NCT00646022 2026-05-12

Natural History of Familial Carcinoid Tumor

National Institutes of Health Clinical Center (CC)

Carcinoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡